History

February, 2011
Nexgenia is incorporated as a Delaware company.

April, 2012
Nexgenia licenses fundamental stimuli-responsive polymer and magnetic nanoparticle technology from the University of Washington.

May, 2012
Nexgenia licenses RAFT polymer synthesis technology from Commonwealth Scientific Industrial Research Organization (CSIRO, Australia).

June, 2012
Nexgenia is awarded Phase 1 SBIR grant – Smart Polymer Reagents for Sensitivity and Speed-enhanced Clinical Diagnostics. Nexgenia leases laboratory and office space in New Ventures Incubator facility on the campus of the University of Washington.

July, 2012
Nexgenia is awarded Life Sciences Discovery Fund grant from the State of Washington – The Scale-up and Optimization of Smart Magnetic Nanoparticle Synthesis. Nexgenia works closely with CSIRO over the course of this grant.

March, 2013
Nexgenia is awarded Phase 2 SBIR grant – Smart Polymer Reagents for Sensitivity and Speed-enhanced Clinical Diagnostics.

August, 2014
Nexgenia is awarded 2nd LSDF Proof of Concept grant from the State of Washington – Development of Conjugate-able, Tempeature-responsive Magnetic Nanoparticles. Read the press release here.

October, 2014
Nexgenia secures seed series financing from The W Fund and the Washington Research Foundation.

Leave a Reply

Your email address will not be published. Required fields are marked *